
New ASCO Guidelines Cover Treatment for Patients with Advanced HER-2 Positive Breast Cancer and Brain Metastases
Author(s) -
Robert H. Carlson
Publication year - 2014
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000451726.72797.29
Subject(s) - pertuzumab , medicine , lapatinib , trastuzumab , trastuzumab emtansine , breast cancer , oncology , metastatic breast cancer , clinical trial , systemic therapy , cancer , palbociclib , guideline , targeted therapy , pathology